Beretta Ventures Announces Changes in Accordance with New CPC Policy Which Became Effective on January 1, 2021
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Beretta Ventures Ltd. (the “Company”) (TSXV:BRTA.H)…
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Beretta Ventures Ltd. (the “Company”) (TSXV:BRTA.H)…
BATON ROUGE, LA / ACCESSWIRE / September 15, 2021 / Investar Holding Corporation (the “Company”)…
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / AMPD Ventures Inc. (“AMPD” or the…
SAN FRANCISCO, CA / ACCESSWIRE / September 15, 2021 / TRON, one of the world’s…
There are people who understand finance and there are people who don’t; Jake Martin is…
TORONTO, ON / ACCESSWIRE / September 15, 2021 / Route1 Inc. (OTCQB:ROIUF and TSXV:ROI) (the…
The Joseph Fund of Camden announces Vince Papale as Bridging the Gap Gala’s Master of…
TAMPA BAY, FL / ACCESSWIRE / September 15, 2021 / Prominent Network Strategist, Alfredo Pino,…
CHONBURI, THAILAND / ACCESSWIRE / September 15, 2021 / Currently emerging as the largest Crypto…
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / Margaret Lake Diamonds Inc. (“MLD” or…
VANCOUVER, BC / ACCESSWIRE / September 15, 2021 / FALCON GOLD CORP. (TSXV:FG)(GR:3FA)(OTCQB:FGLDF); (“Falcon” or…
Executive Director of the Watergate Theatre in Kilkenny, Ireland has written a thought-provoking piece which…
The Clinical Psychologist and Mercer University graduate student debuts an online journal from which she…
MCLEAN, VA / ACCESSWIRE / September 15, 2021 / Cyren (NASDAQ:CYRN), today announced that it…
Research reveals UK delivery customer experience epidemic, with retailers losing customers due to poor post-purchase…
By partnering with Amdaris software developers, RightIndem augmented its existing software expertise and enhanced its…
Netacea reveals how the partnership contributed to evolving its product suite and helped cut onboarding…
OSLO, Norway, Sept. 16, 2021 /PRNewswire/ — Opera GX is introducing iCUE integration that makes CORSAIR…
PRESS RELEASE Launch of Oxitope Pharma, a biopharmaceutical start-up dedicated to the discovery and development…
Metastatic castration-resistant prostate cancer (mCRPC): 21 of 39 patients (54%) achieved ≥ 50% prostate-specific antigen…